Beximco Pharmaceuticals Limited Stock

Equities

BXPHARMA

BD0453BXPH04

Pharmaceuticals

End-of-day quote Dhaka S.E. 06:00:00 2024-06-05 pm EDT 5-day change 1st Jan Change
106.8 BDT -1.11% Intraday chart for Beximco Pharmaceuticals Limited -2.11% -26.95%
Sales 2024 * 44.51B 379M Sales 2025 * 50.42B 429M Capitalization 47.64B 406M
Net income 2024 * 5.25B 44.71M Net income 2025 * 6.24B 53.16M EV / Sales 2024 * 1.2 x
Net Debt 2024 * 5.96B 50.71M Net Debt 2025 * 878M 7.48M EV / Sales 2025 * 0.96 x
P/E ratio 2024 *
8.68 x
P/E ratio 2025 *
7.08 x
Employees 5,700
Yield 2024 *
3.89%
Yield 2025 *
4.92%
Free-Float 76.68%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.11%
1 week-2.11%
Current month-2.11%
1 month-14.29%
3 months-16.89%
6 months-26.95%
Current year-26.95%
More quotes
1 week
105.00
Extreme 105
111.80
1 month
105.00
Extreme 105
126.20
Current year
105.00
Extreme 105
146.20
1 year
105.00
Extreme 105
146.20
3 years
105.00
Extreme 105
255.40
5 years
47.36
Extreme 47.3636
255.40
10 years
31.25
Extreme 31.2513
255.40
More quotes
Managers TitleAgeSince
Director of Finance/CFO 61 89-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Founder - 75-12-31
Founder - 75-12-31
Chief Executive Officer - 84-12-31
More insiders
Date Price Change Volume
24-06-06 106.8 -1.11% 123,453
24-06-05 108 -1.73% 67,468
24-06-04 109.9 +1.76% 168,123
24-06-03 108 -0.46% 62,824
24-06-02 108.5 -0.55% 44,180

End-of-day quote Dhaka S.E., June 05, 2024

More quotes
Beximco Pharmaceuticals Limited is a Bangladesh-based company which is a manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The Company is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. It offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
106.8 BDT
Average target price
177.5 BDT
Spread / Average Target
+66.20%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BXPHARMA Stock